The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings and University Subject Rankings Click here for individual or institutional registration.

Total 31 scientist, 1 country, 1 institution
H-Index Rankings
University / Institution:
# 7
Country:
# 12,998
Region:
# 14,373
World:
# 30,673
H-Index
Total:
69
Last 6 Year:
53
Last 6 Year/Total:
0.768
i10 Index
Total:
156
Last 6 Year:
138
Last 6 Year/Total:
0.885
Citation
Total:
31,595
Last 6 Year:
21,386
Last 6 Year/Total:
0.677
H-Index Rankings
University / Institution:
# 8
Country:
# 16,547
Region:
# 18,371
World:
# 40,189
H-Index
Total:
63
Last 6 Year:
54
Last 6 Year/Total:
0.857
i10 Index
Total:
126
Last 6 Year:
104
Last 6 Year/Total:
0.825
Citation
Total:
60,820
Last 6 Year:
28,646
Last 6 Year/Total:
0.471
H-Index Rankings
University / Institution:
# 9
Country:
# 23,283
Region:
# 26,008
World:
# 59,165
H-Index
Total:
55
Last 6 Year:
52
Last 6 Year/Total:
0.945
i10 Index
Total:
108
Last 6 Year:
100
Last 6 Year/Total:
0.926
Citation
Total:
14,606
Last 6 Year:
13,517
Last 6 Year/Total:
0.925
John D Davis
clinical pharmacology
monoclonal antibodies
drug-drug interactions
pharmacokinetics/pharmacodynamics
H-Index Rankings
University / Institution:
# 17
Country:
# 64,416
Region:
# 72,878
World:
# 198,100
H-Index
Total:
33
Last 6 Year:
24
Last 6 Year/Total:
0.727
i10 Index
Total:
71
Last 6 Year:
44
Last 6 Year/Total:
0.620
Citation
Total:
7,421
Last 6 Year:
5,798
Last 6 Year/Total:
0.781
H-Index Rankings
University / Institution:
# 19
Country:
# 64,861
Region:
# 73,397
World:
# 199,806
H-Index
Total:
33
Last 6 Year:
22
Last 6 Year/Total:
0.667
i10 Index
Total:
72
Last 6 Year:
43
Last 6 Year/Total:
0.597
Citation
Total:
3,244
Last 6 Year:
1,655
Last 6 Year/Total:
0.510
H-Index Rankings
University / Institution:
# 28
Country:
# 91,738
Region:
# 103,839
World:
# 302,109
H-Index
Total:
26
Last 6 Year:
21
Last 6 Year/Total:
0.808
i10 Index
Total:
50
Last 6 Year:
44
Last 6 Year/Total:
0.880
Citation
Total:
2,303
Last 6 Year:
1,829
Last 6 Year/Total:
0.794
Sai Kiran Sharma
Molecular Imaging
Antibody-based therapeutics
immunoPET
Targeted Radiotherapy
Cancer Biology
H-Index Rankings
University / Institution:
# 31
Country:
# 97,262
Region:
# 110,097
World:
# 323,765
H-Index
Total:
25
Last 6 Year:
20
Last 6 Year/Total:
0.800
i10 Index
Total:
37
Last 6 Year:
31
Last 6 Year/Total:
0.838
Citation
Total:
1,668
Last 6 Year:
1,263
Last 6 Year/Total:
0.757
Nidal Al-Huniti
Quantitative Clinical Pharmacology
Clinical Pharmacometrics
Statistics
Drug Development
Clinical
H-Index Rankings
University / Institution:
# 33
Country:
# 103,275
Region:
# 116,878
World:
# 347,536
H-Index
Total:
24
Last 6 Year:
18
Last 6 Year/Total:
0.750
i10 Index
Total:
44
Last 6 Year:
35
Last 6 Year/Total:
0.795
Citation
Total:
2,103
Last 6 Year:
1,374
Last 6 Year/Total:
0.653
Song Nie
Biotherapeutic Protein/AAV Characterization
LC-MS/MS
Bottom-Up Proteomics
Target Proteomics
H-Index Rankings
University / Institution:
# 36
Country:
# 109,403
Region:
# 123,755
World:
# 371,174
H-Index
Total:
23
Last 6 Year:
18
Last 6 Year/Total:
0.783
i10 Index
Total:
27
Last 6 Year:
23
Last 6 Year/Total:
0.852
Citation
Total:
2,655
Last 6 Year:
1,421
Last 6 Year/Total:
0.535
H-Index Rankings
University / Institution:
# 37
Country:
# 110,329
Region:
# 124,798
World:
# 375,426
H-Index
Total:
23
Last 6 Year:
16
Last 6 Year/Total:
0.696
i10 Index
Total:
31
Last 6 Year:
18
Last 6 Year/Total:
0.581
Citation
Total:
1,624
Last 6 Year:
800
Last 6 Year/Total:
0.493
H-Index Rankings
University / Institution:
# 46
Country:
# 121,444
Region:
# 137,248
World:
# 418,479
H-Index
Total:
21
Last 6 Year:
18
Last 6 Year/Total:
0.857
i10 Index
Total:
33
Last 6 Year:
24
Last 6 Year/Total:
0.727
Citation
Total:
2,654
Last 6 Year:
1,849
Last 6 Year/Total:
0.697
H-Index Rankings
University / Institution:
# 52
Country:
# 125,471
Region:
# 141,799
World:
# 435,038
H-Index
Total:
21
Last 6 Year:
12
Last 6 Year/Total:
0.571
i10 Index
Total:
26
Last 6 Year:
17
Last 6 Year/Total:
0.654
Citation
Total:
2,615
Last 6 Year:
667
Last 6 Year/Total:
0.255
H-Index Rankings
University / Institution:
# 54
Country:
# 128,827
Region:
# 145,527
World:
# 447,237
H-Index
Total:
20
Last 6 Year:
18
Last 6 Year/Total:
0.900
i10 Index
Total:
22
Last 6 Year:
20
Last 6 Year/Total:
0.909
Citation
Total:
1,935
Last 6 Year:
957
Last 6 Year/Total:
0.495
H-Index Rankings
University / Institution:
# 56
Country:
# 136,523
Region:
# 154,139
World:
# 478,917
H-Index
Total:
19
Last 6 Year:
17
Last 6 Year/Total:
0.895
i10 Index
Total:
23
Last 6 Year:
20
Last 6 Year/Total:
0.870
Citation
Total:
3,438
Last 6 Year:
2,900
Last 6 Year/Total:
0.844
H-Index Rankings
University / Institution:
# 60
Country:
# 140,382
Region:
# 158,448
World:
# 494,745
H-Index
Total:
19
Last 6 Year:
13
Last 6 Year/Total:
0.684
i10 Index
Total:
22
Last 6 Year:
17
Last 6 Year/Total:
0.773
Citation
Total:
1,338
Last 6 Year:
428
Last 6 Year/Total:
0.320
Jeffery Haines
Neurobiology
Neurodegeneration
Multiple Sclerosis
Progression
Alzheimer's Disease
H-Index Rankings
University / Institution:
# 66
Country:
# 158,739
Region:
# 178,922
World:
# 568,045
H-Index
Total:
17
Last 6 Year:
12
Last 6 Year/Total:
0.706
i10 Index
Total:
19
Last 6 Year:
14
Last 6 Year/Total:
0.737
Citation
Total:
1,388
Last 6 Year:
708
Last 6 Year/Total:
0.510
H-Index Rankings
University / Institution:
# 68
Country:
# 159,307
Region:
# 179,563
World:
# 570,962
H-Index
Total:
17
Last 6 Year:
11
Last 6 Year/Total:
0.647
i10 Index
Total:
21
Last 6 Year:
14
Last 6 Year/Total:
0.667
Citation
Total:
752
Last 6 Year:
379
Last 6 Year/Total:
0.504
H-Index Rankings
University / Institution:
# 78
Country:
# 179,797
Region:
# 202,256
World:
# 652,284
H-Index
Total:
15
Last 6 Year:
11
Last 6 Year/Total:
0.733
i10 Index
Total:
16
Last 6 Year:
12
Last 6 Year/Total:
0.750
Citation
Total:
1,594
Last 6 Year:
757
Last 6 Year/Total:
0.475
Matthew F Wipperman
Precision Medicine
Clinical AI/ML
Digital Health Technology
Clinical Research
Biomarkers
H-Index Rankings
University / Institution:
# 81
Country:
# 182,717
Region:
# 205,476
World:
# 664,934
H-Index
Total:
14
Last 6 Year:
14
Last 6 Year/Total:
1.000
i10 Index
Total:
20
Last 6 Year:
20
Last 6 Year/Total:
1.000
Citation
Total:
1,290
Last 6 Year:
1,092
Last 6 Year/Total:
0.847
H-Index Rankings
University / Institution:
# 87
Country:
# 190,210
Region:
# 213,784
World:
# 694,559
H-Index
Total:
14
Last 6 Year:
11
Last 6 Year/Total:
0.786
i10 Index
Total:
15
Last 6 Year:
11
Last 6 Year/Total:
0.733
Citation
Total:
1,187
Last 6 Year:
702
Last 6 Year/Total:
0.591
H-Index Rankings
University / Institution:
# 92
Country:
# 195,916
Region:
# 220,107
World:
# 719,028
H-Index
Total:
13
Last 6 Year:
13
Last 6 Year/Total:
1.000
i10 Index
Total:
14
Last 6 Year:
14
Last 6 Year/Total:
1.000
Citation
Total:
535
Last 6 Year:
530
Last 6 Year/Total:
0.991
Kishor Devalaraja-Narashimha
Acute kidney injury
Chronic kidney disease
diabetic nephropathy
renal fibrosis
glomerulopathies
H-Index Rankings
University / Institution:
# 96
Country:
# 198,180
Region:
# 222,580
World:
# 727,832
H-Index
Total:
13
Last 6 Year:
12
Last 6 Year/Total:
0.923
i10 Index
Total:
14
Last 6 Year:
13
Last 6 Year/Total:
0.929
Citation
Total:
952
Last 6 Year:
538
Last 6 Year/Total:
0.565
H-Index Rankings
University / Institution:
# 100
Country:
# 201,426
Region:
# 226,161
World:
# 741,307
H-Index
Total:
13
Last 6 Year:
10
Last 6 Year/Total:
0.769
i10 Index
Total:
17
Last 6 Year:
10
Last 6 Year/Total:
0.588
Citation
Total:
858
Last 6 Year:
230
Last 6 Year/Total:
0.268
H-Index Rankings
University / Institution:
# 106
Country:
# 218,901
Region:
# 245,536
World:
# 816,947
H-Index
Total:
11
Last 6 Year:
11
Last 6 Year/Total:
1.000
i10 Index
Total:
13
Last 6 Year:
13
Last 6 Year/Total:
1.000
Citation
Total:
1,394
Last 6 Year:
1,336
Last 6 Year/Total:
0.958
H-Index Rankings
University / Institution:
# 111
Country:
# 223,333
Region:
# 250,419
World:
# 835,940
H-Index
Total:
11
Last 6 Year:
10
Last 6 Year/Total:
0.909
i10 Index
Total:
12
Last 6 Year:
11
Last 6 Year/Total:
0.917
Citation
Total:
407
Last 6 Year:
373
Last 6 Year/Total:
0.916
AD Scientific Index - World Scientists Rankings - 2024 H INDEX i10 INDEX CITATION
University /
Institution
Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
7 12,998 14,373 30,673
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Respiratory drug development | clinical trials |

69 53 0.768 156 138 0.885 31,595 21,386 0.677
8 16,547 18,371 40,189
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Asthma | genetics |

63 54 0.857 126 104 0.825 60,820 28,646 0.471
9 23,283 26,008 59,165
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

biotechnology | genetics | clinical trials |

55 52 0.945 108 100 0.926 14,606 13,517 0.925
17 64,416 72,878 198,100
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

clinical pharmacology | monoclonal antibodies | drug-drug interactions | pharmacokinetics/pharmacodynamics |

33 24 0.727 71 44 0.620 7,421 5,798 0.781
19 64,861 73,397 199,806
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

HEOR |

33 22 0.667 72 43 0.597 3,244 1,655 0.510
28 91,738 103,839 302,109
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

asthma | urticaria | pediatrics | nasal polyps | food allergy |

26 21 0.808 50 44 0.880 2,303 1,829 0.794
31 97,262 110,097 323,765
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Molecular Imaging | Antibody-based therapeutics | immunoPET | Targeted Radiotherapy | Cancer Biology |

25 20 0.800 37 31 0.838 1,668 1,263 0.757
33 103,275 116,878 347,536
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Quantitative Clinical Pharmacology | Clinical Pharmacometrics | Statistics | Drug Development | Clinical |

24 18 0.750 44 35 0.795 2,103 1,374 0.653
36 109,403 123,755 371,174
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Biotherapeutic Protein/AAV Characterization | LC-MS/MS | Bottom-Up Proteomics | Target Proteomics |

23 18 0.783 27 23 0.852 2,655 1,421 0.535
37 110,329 124,798 375,426
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Anti-cancer antibodies and cancer immunotherapy |

23 16 0.696 31 18 0.581 1,624 800 0.493
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

46 121,444 137,248 418,479
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Clinical Pharmacology | Pharmacokinetics | Drug-Drug Interactions | Biologics |

21 18 0.857 33 24 0.727 2,654 1,849 0.697
52 125,471 141,799 435,038
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Diabetes | Obesity | Metabolism |

21 12 0.571 26 17 0.654 2,615 667 0.255
54 128,827 145,527 447,237
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Bone Metastasis | Cancer |

20 18 0.900 22 20 0.909 1,935 957 0.495
56 136,523 154,139 478,917
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Host Microbial relationships |

19 17 0.895 23 20 0.870 3,438 2,900 0.844
60 140,382 158,448 494,745
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Bioanalysis | LC-MS | Biotherapeutics | Biomarker | GLP |

19 13 0.684 22 17 0.773 1,338 428 0.320
66 158,739 178,922 568,045
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Neurobiology | Neurodegeneration | Multiple Sclerosis | Progression | Alzheimer's Disease |

17 12 0.706 19 14 0.737 1,388 708 0.510
68 159,307 179,563 570,962
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

NMR | MRS | MRI |

17 11 0.647 21 14 0.667 752 379 0.504
78 179,797 202,256 652,284
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

immuno-oncology | cancer biology | stress response pathways |

15 11 0.733 16 12 0.750 1,594 757 0.475
81 182,717 205,476 664,934
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Precision Medicine | Clinical AI/ML | Digital Health Technology | Clinical Research | Biomarkers |

14 14 1.000 20 20 1.000 1,290 1,092 0.847
87 190,210 213,784 694,559
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Human disease and therapeutics |

14 11 0.786 15 11 0.733 1,187 702 0.591
92 195,916 220,107 719,028
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Muscle Biology | Metabolism |

13 13 1.000 14 14 1.000 535 530 0.991
96 198,180 222,580 727,832
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Acute kidney injury | Chronic kidney disease | diabetic nephropathy | renal fibrosis | glomerulopathies |

13 12 0.923 14 13 0.929 952 538 0.565
100 201,426 226,161 741,307
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology |

13 10 0.769 17 10 0.588 858 230 0.268
106 218,901 245,536 816,947
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Computational Genetics | Infectious Diseases |

11 11 1.000 13 13 1.000 1,394 1,336 0.958
111 223,333 250,419 835,940
United States Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Huntington's disease | Parkinson's disease |

11 10 0.909 12 11 0.917 407 373 0.916